Found 412 hits.
| 100 | Dölle, S., Hoser, D., Rasche, C., Loddenkemper, C., Maurer, M. Zuberbier, T., and Worm, M.+: Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis. Allergy 2010: 65; 1158-1165. IF: 6.29 |
| 207 | Ngouateu, O. B., Weller, K., Bröhl, K., Kamtchouing, P., Same-Ekobo, A., Dondji, B. , Maurer, M., and Stebut, E.+: Impaired T cell-dependent protection against Leishmania major infection in HIV-positive patients is associated with worsened disease outcome. Exp. Dermatol. 2015: 24; 302-304. IF: 2.67 |
o.207
| 16. | Maurer, M.: Chronic urticaria. In: Zuberbier, T. Grattan, C., and Maurer, M., editors: Urticaria and Angioedema. Heidelberg: Springer, 2010 |
| 17. | Mrabet-Dahbi, S. and Maurer, M.: Innate immunity in atopic dermatitis. In: Shiohara T., Amagai, M., Homey, B., Nakanishi, K., Woodfolk, J. A., Bieber, T., Flohr, C., Schittek, B., Hayakawa, J., Yu, H.-S., Oranje, A. P., Schmid-Grendelmeier, P., and Akdis, C. A., editors: Current Problems in Dermatology „Atopic Dermatitis“. Basel: S. Karger Publishers, 2011 |
| 384. | Sabag, D. A.*, Matanes, L.*, Bejar, J., Sheffer, H., Barzilai, A., Church, M. K., Toubi, E., Maurer, M., and Vadasz, Z.+: Interleukin-17 is a potential player and treatment target in severe chronic spontaneous urticaria. Clin. Exp. Allergy 2020: 50; 799-804. IF: 5.02 |
o.384
| 386. | Chen, Y.-D., Krause, K., Tu, P., Zhao, Z.+, and Maurer, M.+: Response of omalizumab in normocomplementemic urticarial vasculitis. J. Allergy Clin. Immunol. Pract. 2020: 8; 2114-2117. IF: 8.86 |
o.386
| 345 | Krause, K., Sabat, R., Witte-Händel, E., Schulze, A., Puhl, V., Maurer, M., and Wolk, K.+: Association of CCL2 with systematic inflammation in Schnitzler syndrome. Br. J. Dermatol. 2019: 180; 859-868. IF: TBD (IF 2018: 6.71) |
| 211 | Casale, T. B., Bernstein, J. A., Maurer, M. Saini, S. S., Trzaskoma, B., Chen, H., Grattan, C., Gimenèz-Arnau, A., Kaplan, A. P., and Rosén, K.+: Similar efficacy with Omalizumab in chronic idiopathic/spontaneous urticaria despite different background therapy. J. Allergy Clin. Immunol. Pract. 2015: 3; 743-750. IF: 5.42 |
| 134 | Kocatürk, E.+, Weller, K., Martus, P., Aktas, S., Kavala, M., Sarigul, S., Baiardini, I., Canonica, G. W., Brzoza, Z., Kalogeromitros, and Maurer, M.: Turkish version of the chronic urticaria quality of life questionnaire: cultural adaption, assessment of reliability and validity. Acta Derm. Venereol. 2012: 92; 419-425. IF: 3.48 |
o.134
| 219 | Weller, K.+, Maurer, M. Grattan, C., Nakonechna, A., Abuzakouk, M., Bérard, F., Sussman, G., Giménez-Arnau, A. M., Ortiz de Frutos, J., Knulst, A., Canonica, G. W., Hollis, K., McBride, D., and Balp, M. M.: ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria. Clin. Transl. Allergy 2015: 5; 29. IF N/A |